Click a link below to view the mailing archive as if it had been sent to you.
| 2017-12-30 12:15 | | 4 Biotechs Ready to Kill the Market in 2018 and more... |
| 2017-12-29 12:15 | | Fresenius oncology drug plant slammed with new warning letter and more... |
| 2017-12-28 12:15 | | 3 Bold Biotech Predictions For 2018! and more... |
| 2017-12-27 12:15 | | SEC subpoenas Ocular Therapeutix over pain relief implant and more... |
| 2017-12-26 12:15 | | Here's How AbbVie Inc. Crushed It in 2017 and more... |
| 2017-12-24 00:15 | | Biopharma trends to watch in 2018 and more... |
| 2017-12-23 12:15 | | Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels and more... |
| 2017-12-22 12:15 | | Roche Bets $1.7B More on Precision Oncology With Ignyta Deal and more... |
| 2017-12-22 00:15 | | New Drug Approvals for FDA: 2017 Matches All-Time High and more... |
| 2017-12-21 12:15 | | Spending on prescription drugs has almost doubled since the '90s, report finds and more... |
| 2017-12-21 00:15 | | Why 2018 is a make-or-break year for pharma and more... |
| 2017-12-20 12:15 | | Another death mars AbbVie’s latest batch of promising data for its star rheumatoid arthritis drug and more... |
| 2017-12-20 00:15 | | Allergan, Gedeon Richter plan depression submission and more... |
| 2017-12-19 12:15 | | Boehringer Ingelheim inks CNS deal with Autifony and more... |
| 2017-12-18 12:15 | | How biopharma wins through tax reform and more... |
| 2017-12-17 12:15 | | Strike Over Teva Firings Shuts Israel Bourse, Banks, Airport and more... |
| 2017-12-16 12:15 | | Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales? and more... |
| 2017-12-16 00:15 | | Mylan Announces IPR Proceedings for Sanofi's Lantus Patents and more... |
| 2017-12-15 12:15 | | Boston Scientific settles over 370 pelvic mesh lawsuits and more... |
| 2017-12-15 00:15 | | FDA to Pharma Firms: Update or Certify Drug Listings by End of Month and more... |
| 2017-12-14 12:15 | | Express Scripts Will Seek 'Targeted Acquisitions' To Bolster Business and more... |
| 2017-12-14 00:15 | | Will This Drug Kick-Start Regeneron Pharmaceuticals Shares? and more... |
| 2017-12-13 12:15 | | Merck says it has restored most of its manufacturing hit by cyberattack and more... |
| 2017-12-13 00:15 | | Teva turnover continues with resignation of former chairman, interim chief and more... |
| 2017-12-12 12:15 | | Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline and more... |
| 2017-12-12 00:15 | | Roche's Fight With Pfizer May Be Just The Beginning and more... |
| 2017-12-11 12:15 | | Teva's job-cut tally could touch 10K: report and more... |
| 2017-12-11 00:15 | | New rumors about massive layoffs in Teva and more... |
| 2017-12-10 12:15 | | Hospitals Merge To Protect Turf As CVS And Optum Move In and more... |
| 2017-12-10 00:15 | | ASH17: BioMarin's gene therapy promises one-time treatment of hemophilia and more... |
| 2017-12-09 00:15 | | M&A slows to a trickle in 2017, but Big Pharma could be on deck for mega deals |
| 2017-12-08 12:15 | | Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal and more... |
| 2017-12-08 00:15 | | Roche's Tecentriq combo cuts risk of lung cancer progression and more... |
| 2017-12-07 12:15 | | Why 2017 Was a Year to Forget for Merck & Co. Inc. and more... |
| 2017-12-07 00:15 | | Viagra goes generic: Pfizer to launch own little white pill and more... |
| 2017-12-06 12:15 | | Settle down, Allergan investors. Botox's market share is safe, analysts say and more... |
| 2017-12-06 00:15 | | Troubled Depomed sells off Nucynta, axes 40% of workforce to pare down costs and more... |
| 2017-12-05 12:15 | | How will the pharma industry fare in 2018 under Trump? and more... |
| 2017-12-05 00:15 | | Will 2018 Be Johnson & Johnson's Best Year Yet? and more... |
| 2017-12-04 12:15 | | Three Takeaways From The CVS-Aetna Merger and more... |
| 2017-12-04 00:15 | | CVS agrees to buy insurance giant Aetna |
| 2017-12-03 12:15 | | Amazon in talks with generic drugmakers including Mylan, Sandoz about pharma play: report and more... |
| 2017-12-02 12:15 | | FDA Approves Eighth Biosimilar, First for Cancer Drug Herceptin and more... |
| 2017-12-02 00:15 | | Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal and more... |
| 2017-12-01 12:15 | | Bayer decides it's time to stick research and development together and more... |
